Neurobiological Technologies, Inc.

NTIIOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$2702

P/E Ratio—

52W High$0.0001

52W Low$0.000001

Avg Volume895.664

Open$0.00

Beta-410.84

Overview

Neurobiological Technologies, Inc. (NTII) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

NTII · earnings · updated Jun 9, 2026

Latest Earnings

Q4 FY2008Report Date: Nov 6, 2008

EPS Actual

-$0.10

Est. -$0.16 · +37.5%

Revenue

—

Fiscal Period

Q4 FY2008

FY ends December

Report Date

Nov 6, 2008

After Market Close

▲ Beat EPS✓ 2-Quarter EPS Beat Streak

NTII reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
▲ Q4 FY2008	Nov 6, 2008	-$0.16	-$0.10	+37.5%	—	—	—
▲ Q2 FY2008	May 12, 2008	-$0.21	-$0.19	+9.5%	—	—	—
▼ Q1 FY2008	Feb 11, 2008	-$0.19	-$0.36	-89.5%	—	—	—
▼ Q3 FY2007	Sep 13, 2007	-$0.14	-$0.91	-550.0%	—	—	—
▼ Q2 FY2007	May 9, 2007	-$0.84	-$1.05	-25.0%	—	—	—
▲ Q1 FY2007	Feb 8, 2007	-$0.91	-$0.77	+15.4%	—	—	—
— Q3 FY2006	Aug 15, 2006	—	-$1.12	—	—	—	—
▼ Q2 FY2006	May 10, 2006	-$0.49	-$0.91	-85.7%	—	—	—

Q4 FY2008

Nov 6, 2008Beat

EPS Actual

-$0.10

EPS Est.

-$0.16

EPS Surpr.

+37.5%

Revenue

—

Q2 FY2008

May 12, 2008Beat

EPS Actual

-$0.19

EPS Est.

-$0.21

EPS Surpr.

+9.5%

Revenue

—

Q1 FY2008

Feb 11, 2008Miss

EPS Actual

-$0.36

EPS Est.

-$0.19

EPS Surpr.

-89.5%

Revenue

—

Q3 FY2007

Sep 13, 2007Miss

EPS Actual

-$0.91

EPS Est.

-$0.14

EPS Surpr.

-550.0%

Revenue

—

Q2 FY2007

May 9, 2007Miss

EPS Actual

-$1.05

EPS Est.

-$0.84

EPS Surpr.

-25.0%

Revenue

—

Q1 FY2007

Feb 8, 2007Beat

EPS Actual

-$0.77

EPS Est.

-$0.91

EPS Surpr.

+15.4%

Revenue

—

Q3 FY2006

Aug 15, 2006

EPS Actual

-$1.12

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2006

May 10, 2006Miss

EPS Actual

-$0.91

EPS Est.

-$0.49

EPS Surpr.

-85.7%

Revenue

—

No analyst estimates available for NTII.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▲ Q4 FY2008	Nov 6, 2008	+37.5%	$0.69	$0.69	+0.01%
▲ Q2 FY2008	May 12, 2008	+9.5%	$2.15	$2.16	+0.47%
▼ Q1 FY2008	Feb 11, 2008	-89.5%	$2.64	$2.49	-5.68%
▼ Q3 FY2007	Sep 13, 2007	-550.0%	$5.88	$5.88	+0.00%
▼ Q2 FY2007	May 9, 2007	-25.0%	$14.21	$14.14	-0.49%
▲ Q1 FY2007	Feb 8, 2007	+15.4%	$18.62	$18.55	-0.35%
— Q3 FY2006	Aug 15, 2006	—	$18.55	$18.20	-1.89%
▼ Q2 FY2006	May 10, 2006	-85.7%	$23.73	$22.96	-3.24%

Q4 FY2008+0.01%

Report Date

Nov 6, 2008

EPS Beat/Miss

+37.5%

Price Before

$0.69

Price After

$0.69

Q2 FY2008+0.47%

Report Date

May 12, 2008

EPS Beat/Miss

+9.5%

Price Before

$2.15

Price After

$2.16

Q1 FY2008-5.68%

Report Date

Feb 11, 2008

EPS Beat/Miss

-89.5%

Price Before

$2.64

Price After

$2.49

Q3 FY2007+0.00%

Report Date

Sep 13, 2007

EPS Beat/Miss

-550.0%

Price Before

$5.88

Price After

$5.88

Q2 FY2007-0.49%

Report Date

May 9, 2007

EPS Beat/Miss

-25.0%

Price Before

$14.21

Price After

$14.14

Q1 FY2007-0.35%

Report Date

Feb 8, 2007

EPS Beat/Miss

+15.4%

Price Before

$18.62

Price After

$18.55

Q3 FY2006-1.89%

Report Date

Aug 15, 2006

EPS Beat/Miss

—

Price Before

$18.55

Price After

$18.20

Q2 FY2006-3.24%

Report Date

May 10, 2006

EPS Beat/Miss

-85.7%

Price Before

$23.73

Price After

$22.96

Avg Beat Reaction+0.04%

Avg Miss Reaction-2.35%

Beat Rate3 / 8 quarters

Largest Move-5.68% (Q1 FY2008)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Neurobiological Technologies, Inc. (NTII) most recently reported earnings on November 6, 2008 for Q4 FY2008, posting EPS of $-0.10 — beating the analyst consensus of $-0.16 by +37.5%. NTII has beaten EPS estimates for 2 consecutive quarters. The next NTII earnings date is expected around September 1, 2026.

Each quarter, investors track NTII earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NTII revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

NTII's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

NTII earnings · 5 questions

Neurobiological Technologies, Inc.'s next earnings report is expected around September 1, 2026. NTII typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NTII historically reports after market close (AMC).

NTII earnings datewhen is NTII earningsNTII next earnings datewhen does NTII report earningsNTII earnings calendar

▸ Source: FMP · Neurobiological Technologies, Inc. SEC filings · US GAAP · Neurobiological Technologies, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026